Through empowering and educating patients, funding cutting-edge research, building strategic collaborations and raising public awareness, our goal is to transform lung cancer into a chronically managed disease within 10 years and ultimately to find a cure.

Latest News
Patient-driven ResearchPatient-driven Research // .pn-featured-image { display: none; } .meta a { display: none; } Early detection survivors and patient-driven groups such as the EGFR Resisters, ALK Positive and ROS1ders have joined forces with... Read More READ MORE